Beeline Medicines Funding: $426M Raised, Series A (2026)
Beeline Medicines is a Biotech company based in Boston, Massachusetts. It has raised $426M in total funding. Latest round: Series A. Backed by Bain Capital.
Beeline Medicines funding overview
Beeline Medicines is a Biotech company based in Boston, Massachusetts. Beeline Medicines has raised $426M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in April 2026. The round record for Beeline Medicines runs through 2026; nothing later has been disclosed. Investors on record include Bain Capital.
Beeline Medicines at a glance
Total raised
$426M
Latest round
Series A
Latest round date
April 2026
Industry
Biotech
Headquarters
Boston, Massachusetts
Notable investors
Bain Capital
Frequently asked about Beeline Medicines funding
How much has Beeline Medicines raised?
Beeline Medicines has raised $426M in total disclosed funding across the rounds on record.
Who has invested in Beeline Medicines?
Bain Capital are named among the investors backing Beeline Medicines.
What was the latest Beeline Medicines funding round?
The most recent disclosed round is a Series A, announced in April 2026.
Where is Beeline Medicines based?
Beeline Medicines is based in Boston, Massachusetts.
What sector does Beeline Medicines operate in?
Beeline Medicines is tracked under Biotech from Boston, Massachusetts, with $426M in disclosed funding.
When did Beeline Medicines last raise?
The last disclosed Beeline Medicines round closed in April 2026 at Series A.
Totals shown for Beeline Medicines aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
